Latest news
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 04:31:46 GMTAustralia’s Victoria advances mRNA trials with $1.41m grants - Healthcare Asia MagazineHealthcare Asia Magazine · Mon, 10 Aug 2026 03:03:30 GMTCAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances - The American Journal of Managed CareThe American Journal of Managed Care · Sat, 08 Aug 2026 23:42:43 GMTDr. David Sinclair Launches Lifespan, the First Science Media Platform Built by Longevity Scientists to Advance Medical Research - PR NewswirePR Newswire · Fri, 07 Aug 2026 20:02:00 GMTAxoft Secures $55M Series A to Advance Clinical Trials Globally f - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 08:53:41 GMTFDA Approves Tudriqev for Anti-PD-1 Resistant Advanced Melanoma - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 07:31:37 GMTCAMP4 advances rare disease treatment for SYNGAP1 into human trials - CNBCCNBC · Thu, 06 Aug 2026 18:52:12 GMTS.D.-born biotech advances potential Type 1 diabetes therapy through global trial - SiouxFalls.BusinessSiouxFalls.Business · Thu, 06 Aug 2026 14:35:40 GMT